The role of miR-129-5p in regulating γ-globin expression and erythropoiesis in β-thalassemia
- PMID: 39657657
- DOI: 10.1093/hmg/ddae180
The role of miR-129-5p in regulating γ-globin expression and erythropoiesis in β-thalassemia
Abstract
The regulation of γ-globin expression is crucial due to its beneficial effects on diseases like β-thalassemia and sickle cell disease. B-cell lymphoma/leukemia 11A (BCL11A) is a significant suppressor of γ-globin, and microRNAs (miRNAs) targeting BCL11A have been shown to alleviate this suppression. In our previous high-throughput sequencing, we identified an 11.32-fold increase in miR-129-5p expression in β-thalassemia patients. However, the regulatory mechanisms of miR-129-5p in the context of erythroid differentiation remain to be elucidated. Our study aimed to elucidate the role of miR-129-5p in γ-globin regulation and erythropoiesis. We measured miR-129-5p levels in peripheral blood from β-thalassemia major and intermedia patients. Fluorescence in situ hybridization, dual-luciferase reporter assays, miRNA pull down assays and western blot analyses were conducted to examine the effects of miR-129-5p on γ-globin expression and BCL11A repression. Cell proliferation, apoptosis, and erythroid differentiation were assessed using cell counting kit-8, Wright-Giemsa, and benzidine staining, and flow cytometry assays. The expression levels of miR-129-5p were significantly elevated in β-thalassemia patients and positively correlated with γ-globin synthesis while negatively correlating with liver damage. miR-129- 5p enhanced γ-globin gene expression in K562 and HUDEP-2 cells by effectively repressing BCL11A. Overexpression of miR-129-5p inhibited cell proliferation, induced cell cycle arrest at the G1/G0 phase, promoted apoptosis and stimulated erythroid differentiation and maturation. Conversely, inhibition of miR-129-5p produced opposite cellular effects. miR-129-5p acts as a positive regulator of erythroid differentiation and γ-globin synthesis. It offers a promising miRNA target for activating the γ-globin gene and reducing ineffective erythropoiesis in β-thalassemia patients.
Keywords: BCL11A; erythroid differentiation; miR-129-5p; β-thalassemia; γ-globin.
© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Upregulation of miR-17-3p is associated with HbF in patients with β-thalassemia and induces γ-globin expression by targeting BCL11A.Orphanet J Rare Dis. 2025 May 30;20(1):260. doi: 10.1186/s13023-025-03806-0. Orphanet J Rare Dis. 2025. PMID: 40448206 Free PMC article.
-
miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.Mol Biol Rep. 2020 May;47(5):3909-3918. doi: 10.1007/s11033-020-05483-7. Epub 2020 May 13. Mol Biol Rep. 2020. PMID: 32406020
-
MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.Hematology. 2022 Dec;27(1):1152-1162. doi: 10.1080/16078454.2022.2128258. Hematology. 2022. PMID: 36178486
-
The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment.Cardiovasc Hematol Disord Drug Targets. 2023;22(4):226-236. doi: 10.2174/1871529X23666230123140926. Cardiovasc Hematol Disord Drug Targets. 2023. PMID: 36734897 Review.
-
MicroRNAs in β-thalassemia.Am J Med Sci. 2021 Jul;362(1):5-12. doi: 10.1016/j.amjms.2021.02.011. Epub 2021 Feb 16. Am J Med Sci. 2021. PMID: 33600783 Review.
MeSH terms
Substances
Grants and funding
- 2021Y2012/Innovation Platform Project of Science and Technology, Fujian province
- 2023J011217/Fujian Provincial Natural Science Foundation of China
- 2023Y9364/Joint Funds for the Innovation of Science and Technology of Fujian Province
- 81970170/National Natural Science Foundation of China
- 2023ZQNZD009/Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province
LinkOut - more resources
Full Text Sources
Research Materials